Showing 1 – 2 of 2
Relevance | Newest | Oldest |
  • Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus

    Abstract Full Text
    online first
    JAMA. 2024; 10.1001/jama.2024.5859

    This Viewpoint discusses recommendations from the US Centers for Disease Control and Prevention for newly licensed immunizations for respiratory syncytial virus in infants, children with high-risk conditions, and older adults.

  • Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2

    Abstract Full Text
    open access is active quiz
    ÁñÁ«ÊÓƵ Netw Open. 2021; 4(6):e2116420. 10.1001/jamanetworkopen.2021.16420

    This cohort study examines the incidence of multisystem inflammatory syndrome in children among persons in the US with SARS-CoV-2 infection.